Our study identifies four dendritic cell (DC) subsets associated with CRC development: Myeloid DC %DC and CCR2 on CD62L+ myeloid DC are risk factors for CRC, while CD86+ plasmacytoid DC %DC and CD62L- monocyte %monocyte serve as protective factors. This evidence concerns the gene SELL and colorectal carcinoma.